Skip to main content
Tech.euFundingExplorerBeta

EarlySight

EarlySight uses a novel approach to provide a single cell level imaging of the back of the eye, called the retina.

EarlySight has raised €5.4M across 2 funding rounds from 6 investors, most recently a Seed round in Sep 2025. Based in Zurich, Switzerland; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€5.4M
€5,416,970
Funding rounds
2
Investors
6
distinct backers
Active since
2021-05
latest 2025-09

Funding by year

EUR raised per year
EarlySight — funding by year — interactive chart.
Data table
EarlySight — funding by year
2021€2.1M
2025€3.3M

Signals

High confidence
Raise-next likelihood70
base rate 44% for Seed
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood15
base rate 11% (2+ rounds)
  • ▲ 5y since founding (typical exit age)
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Similar companies

same sector or country

Global coverage: FundingData